We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AEON.WS icon
701
DELISTED
AEON Biopharma Inc
AEON.WS
$4K ﹤0.01%
112,473
– –
2021 Q2
6 quarters
CSTA.WS
702
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$4K ﹤0.01%
144,156
– –
2022 Q1
3 quarters
LIONW icon
703
DELISTED
Lionheart III Corp Warrant
LIONW
$4K ﹤0.01%
95,450
– –
2021 Q4
4 quarters
FNVTW icon
704
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$3K ﹤0.01%
134,651
– –
2021 Q4
4 quarters
RJAC.WS
705
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$3K ﹤0.01%
302,018
-2,955
-1% -$126
2022 Q1
3 quarters
OPTXW icon
706
Syntec Optics Holdings Warrant
OPTXW
$25.3M
$2K ﹤0.01%
49,491
– –
2022 Q1
3 quarters
RRC icon
707
PUT
Range Resources
RRC
$9.83B
$2K ﹤0.01%
35,400
– –
2021 Q2
6 quarters
VRNA
708
PUT
DELISTED
Verona Pharma
VRNA
$2K ﹤0.01%
+91,000
New +$1.21M
2022 Q4
0 quarters
APXIW icon
709
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$2K ﹤0.01%
94,414
– –
2022 Q1
3 quarters
DISAW
710
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$2K ﹤0.01%
86,876
– –
2021 Q2
6 quarters
FSRXW
711
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$2K ﹤0.01%
306,249
– –
2022 Q1
3 quarters
ALORW
712
DELISTED
ALSP Orchid Acquisition Corp I Warrant
ALORW
$2K ﹤0.01%
64,956
– –
2022 Q1
3 quarters
CRZNW
713
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$2K ﹤0.01%
79,540
– –
2021 Q2
6 quarters
BAX icon
714
CALL
Baxter International
BAX
$12.7B
$1K ﹤0.01%
+14,200
New +$763K
2022 Q4
0 quarters
H icon
715
PUT
Hyatt Hotels
H
$15.2B
$1K ﹤0.01%
17,500
– –
2022 Q1
3 quarters
RDZNW icon
716
Roadzen Inc Warrants
RDZNW
$5.4M
$1K ﹤0.01%
71,020
– –
2022 Q2
2 quarters
TVGNW icon
717
Tevogen Inc Warrant
TVGNW
$1.41M
$1K ﹤0.01%
192,665
– –
2022 Q1
3 quarters
SDSTW icon
718
Stardust Power Inc Warrant
SDSTW
$1K ﹤0.01%
37,984
– –
2021 Q1
7 quarters
BSLKW
719
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$1K ﹤0.01%
171,364
– –
2022 Q1
3 quarters
BLUA.WS icon
720
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$1K ﹤0.01%
51,138
– –
2022 Q1
3 quarters
GVCIW
721
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
$1K ﹤0.01%
99,444
– –
2022 Q1
3 quarters
LGACW
722
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$1K ﹤0.01%
139,748
– –
2021 Q2
6 quarters
THACW
723
DELISTED
Thrive Acquisition Corporation Warrant
THACW
$1K ﹤0.01%
73,354
– –
2021 Q4
4 quarters
TZPSW
724
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$1K ﹤0.01%
112,473
– –
2021 Q1
7 quarters
AAPL icon
725
PUT
Apple
AAPL
$5.05T
– –
-100,000
Closed -$1.28M –
27 28
29
30 31

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.